FAMI vs SRXH

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 11, 2026

FAMI

28.5
AI Score
VS
SRXH Wins

SRXH

53.1
AI Score

Investment Advisor Scores

FAMI

29score
Recommendation
SELL

SRXH

53score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric FAMI SRXH Winner
Revenue 27.97M 6.53M FAMI
Net Income -53.10M -45.01M SRXH
Gross Margin 2.9% 23.4% SRXH
Net Margin -189.8% -688.8% FAMI
Operating Income -56.12M -11.41M SRXH
ROE -42.8% -11058.0% FAMI
ROA -36.1% -535.7% FAMI
Total Assets 147.03M 8.40M FAMI
Current Ratio 9.35 2.29 FAMI

Relative Price Performance (Last 90 Days)

FAMI 1M: -4.7% · 3M: -87.5% SRXH 1M: -10.6% · 3M: +1185.2%

Current Technical Phase

FAMI

Markdown
Sell / avoid

Price below a falling SMA50 (slope -71.1%), weak momentum, RSI 42

RSI (14): 41.5 · Price: $0.12

SRXH

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 51

RSI (14): 50.6 · Price: $1.65

Fundamentals Snapshot

Metric FAMI SRXH
Market Cap
Forward P/E 0.0 0.0
Trailing P/E
Revenue (TTM)
Revenue Growth -0.6% -0.1%
Gross Margin -0.1% 0.3%
Operating Margin -4.9% -0.9%
EPS -32.13 -126.48
Dividend Yield 0.00%

Frequently Asked Questions

Based on our detailed analysis, SRXH is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.